Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Vijay Baichwal"'
Autor:
Arne Christians, Katherine Elston, Jessica Runyon, Vijay Baichwal, Weston Stauffer, Analise Leddy, Savannah Santoro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/1f25c4f2d9a944c997882383e20a4877
Autor:
Brandi L. Williams, Robert O. Carlson, Daniel A. Wettstein, D. Vijay Kumar, Hoarau Christophe, Michael Saunders, J. Adam Willardsen, Ian McAlexander, Vijay Baichwal, Damon I. Papac, Kirill Ostanin, Mark A. Hess, Thaylon Davis, Irene Dorweiler, Rosann Robinson, Thomas B. Douce, Ashley Peterson, Rena McKinnon, Daniel M. Cimbora, Bruce L. Roth, Jared Cassiano, Aaron Rogers, Keith D. Tardif
PDF file - 123K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283c8eaa2dca423394832ac961f466f3
https://doi.org/10.1158/1535-7163.22497223
https://doi.org/10.1158/1535-7163.22497223
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Cancer Research. 83:4634-4634
Molecular subtyping studies have allowed the allocation of cancer into groups based on similar molecular, morphological, and clinical characteristics. Such studies are critical to help researchers identify actionable targets for drug design and bioma
Autor:
Damon I. Papac, Rena McKinnon, Ashok C. Bajji, Vijay Baichwal, Rosann Robinson, Richard Trovato, Daniel Wettstein, Paul L. Bartel, Rajendra P. Tangallapally, Kraig M. Yager, Daniel M. Cimbora, Robert O. Carlson, Se-Ho Kim, Mark D. Shenderovich, Benjamin Markovitz
Publikováno v:
Journal of Medicinal Chemistry. 55:7480-7501
Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. This has spurred the search for small-molecule Hsp90 in
Autor:
Rena McKinnon, In Chul Kim, Vijay Baichwal, Harry Austin, Esther Arranz-Plaza, Kraig M. Yager, David Gerrish, Dange Vijay Kumar, Mark B. Anderson, Jennifer E. Garrus, Robert O. Carlson, Michael Saunders
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:6377-6380
Efforts towards developing orally bioavailable HIV-1 maturation inhibitors starting from betulinic acid 1 are described. SAR resulted in improved potency, physicochemical properties, and enhanced oral absorption in rats.
Autor:
John Drewe, Kevin Jessing, Raouf A. Hussain, Christopher M. Pleiman, Khanh C. Hoang, Nilantha Sudath Sirisoma, Songchun Jiang, Gary Mather, Hong Zhang, Azra Pervin, Ben Tseng, Vijay Baichwal, Shailaja Kasibhatla, J. Adam Willardsen, Sui Xiong Cai, Mark B. Anderson
Publikováno v:
Journal of Medicinal Chemistry. 51:4771-4779
Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine, co
Autor:
Bruce J. Roth, Nilantha Sudath Sirisoma, Robert O. Carlson, Azra Pervin, Vijay Baichwal, Ira Skvortsova, Shailaja Kasibhatla, Ben Tseng, Sergej Skvortsov, John Drewe, Sui Xiong Cai, Peter Lukas, Christopher M. Pleiman, Nicole English
Publikováno v:
Cancer Research. 67:5865-5871
A novel series of 4-arylaminoquinazolines were identified from a cell-based screening assay as potent apoptosis inducers. Through structure-activity relationship studies, MPC-6827 and its close structural analogue, MPI-0441138, were discovered as pro
Autor:
Se-Ho Kim, Damon I. Papac, Robert W. Carlson, Rajendra Tangallapally, In Chul Kim, Kraig M. Yager, Chad Bradford, Richard Trovato, Leslie Reeves, Daniel P. Parker, J. Scott Patton, Vijay Baichwal, Ashok C. Bajji, Daniel Wettstein
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(22)
Various types of Hsp90 inhibitors have been and continue to undergo clinical investigation. One development candidate is the purine-based, synthetic Hsp90 inhibitor 1 (MPC-3100), which successfully completed a phase I clinical study. However, further
Autor:
Susan Schwender, Holger Beckmann, David Clark, Martin Thoolen, Vijay Baichwal, Walter Frankmoelle, Steven M. Rubenstein, Daniel Roche, Juan C. Jaen, Qiuping Ye, Edit Santha
Publikováno v:
Journal of Medicinal Chemistry. 44:3599-3605
The novel anticancer compound T138067 is an irreversible inhibitor of tubulin polymerization. Amides 3-6 were synthesized using standard methodologies and determined to be significantly less lipophilic than T138067 based on logP calculations. Tubulin